Reactive arthritis: incidence, triggering agents and clinical presentation
about
HLA-B27-associated reactive arthritis: pathogenetic and clinical considerationsA monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritisThe incidence of sexually acquired reactive arthritis: a systematic literature review.Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts.Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue.The epidemiology of infectious gastroenteritis related reactive arthritis in U.S. military personnel: a case-control study.Functional CCR5 receptor protects patients with arthritis from high synovial burden of infecting Chlamydia trachomatis.Modes of presentation of reactive arthritis based on the affected joints.Incidence and prevalence of juvenile arthritis in an urban population of southern Germany: a prospective studyFrequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis.Male sex predominance in Chlamydia trachomatis sexually acquired reactive arthritis: are women more protected by anti-chlamydia antibodies?Annual incidence of inflammatory joint diseases in a population based study in southern SwedenThree month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled studyEpidemiology of spondyloarthritis.Long-term health risks for children and young adults after infective gastroenteritis.The genetics of human autoimmune disease: A perspective on progress in the field and future directions.The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis.Campylobacter reactive arthritis: a systematic reviewTHE SOURCE OF INFECTION AND THE MOST FREQUENT CAUSES OF REACTIVE ARTHRITIS IN KOSOVO.Expression of inflammatory host genes in Chlamydia trachomatis-infected human monocytes.Persistent infection of Chlamydia in reactive arthritis.Autoinflammation and HLA-B27: Beyond Antigen Presentation.Shigella induced reactive arthritis.Spondyloarthritis, Acute Anterior Uveitis, and Fungi: Updating the Catterall-King Hypothesis.IL-12/23p40 overproduction by dendritic cells leads to an increased Th1 and Th17 polarization in a model of Yersinia enterocolitica-induced reactive arthritis in TNFRp55-/- mice.
P2860
Q24625587-C3E06C80-1AF8-451F-AAE6-3885C8CEA2BCQ28572406-6849553D-BF80-44F3-8269-BB03A36966A3Q30248663-A7739A04-8AFC-4ECF-8EE8-EDC4D7A073E4Q33579187-B7ADA1FA-C6F6-4BC7-993A-330BC3C27AAAQ33625685-013784CB-621C-4064-A1B9-B5F632AA2FD8Q33690915-1FE54B98-128B-452C-A860-66B763D1E01BQ34372582-5B17D398-1AA8-437D-B49C-DC679CDF1111Q35262914-7988ED5F-4F27-45FC-9E8F-2E8D0347DFAAQ35549801-B85B59DD-C289-4D56-AD54-82ED8DC0A2CBQ35550301-C6BDCBB2-6C0C-479B-971A-3E2F241F85C6Q35550514-7CCECE26-5430-440D-BAC5-41294F57117BQ35551002-205CD1E2-F07D-4EE7-A38D-EFB34D198BEEQ35554555-C6E6BEB4-4599-46FC-87A6-99BB93F21BEBQ35750729-5C458F37-B537-4D8F-A087-DB3EFC4DF899Q35806480-CAC712B3-3CD5-4230-A18D-04292AB1D360Q36236745-6E58716C-01B5-4F27-8E75-F00E93A7462DQ36630577-35CDD161-CF36-4846-B978-B56387889AADQ36759683-EEFE1DC4-21F7-4B08-B7BF-047AADD9F1E5Q37104191-7113A004-F512-426B-A79B-D281CF25FADAQ37859710-118471AD-5881-478A-B975-062F05B606BAQ37862920-346071B9-D91D-48E8-8C05-DCF1226A85EEQ38845301-B7FD506C-278E-4CBE-B4EF-EC324A68C59AQ43048944-24422E1C-B52E-4258-A3F6-7F38969693ABQ52575771-91D69D3F-1C9C-479E-A221-07C0DBCC3403Q52679480-BC411A16-9FD7-4201-BC85-0D58CC2B72A4
P2860
Reactive arthritis: incidence, triggering agents and clinical presentation
description
1994 nî lūn-bûn
@nan
1994 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Reactive arthritis: incidence, triggering agents and clinical presentation
@ast
Reactive arthritis: incidence, triggering agents and clinical presentation
@en
Reactive arthritis: incidence, triggering agents and clinical presentation
@nl
type
label
Reactive arthritis: incidence, triggering agents and clinical presentation
@ast
Reactive arthritis: incidence, triggering agents and clinical presentation
@en
Reactive arthritis: incidence, triggering agents and clinical presentation
@nl
prefLabel
Reactive arthritis: incidence, triggering agents and clinical presentation
@ast
Reactive arthritis: incidence, triggering agents and clinical presentation
@en
Reactive arthritis: incidence, triggering agents and clinical presentation
@nl
P2093
P1476
Reactive arthritis: incidence, triggering agents and clinical presentation
@en
P2093
P304
P407
P577
1994-01-01T00:00:00Z